Intrexon reported $104.86M in Current Liabilities for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Agenus AGEN:US USD 173.07M 13.35M
Amgen AMGN:US USD 14.33B 1.71B
Anika Therapeutics ANIK:US USD 26.35M 3.08M
Arrowhead Research ARWR:US USD 138.85M 10.64M
AstraZeneca AZN:LN USD 24.85B 3.04B
Bluebird Bio BLUE:US USD 126.73M 22.13M
Bristol Myers Squibb BMY:US USD 18.93B 1.98B
Gilead Sciences GILD:US USD 10.42B 1.2B
GlaxoSmithKline GSK:LN GBP 20.95B 16.88B
Heron Therapeutics HRTX:US USD 93.88M 15.62M
Immunogen IMGN:US USD 103.64M 16.57M
Intrexon XON:US USD 104.86M 74.96M
Karyopharm Therapeutics KPTI:US USD 61.76M 780K
Ligand Pharmaceuticals LGND:US USD 135.24M 32.61M
Macrogenics MGNX:US USD 50.05M 831K
Mannkind MNKD:US USD 59.6M 33K
Merk MRK:US USD 23B 170M
Novartis NOVN:VX USD 28.16B 514M
Peregrine Pharmaceuticals PPHM:US USD 82.38M 10.97M
Rigel Pharmaceuticals RIGL:US USD 47.26M 7.69M
Roche Holding ROG:VX 27.41B 11.01B
Sangamo Biosciences SGMO:US USD 122.36M 2.37M
Thermo Fisher Scientific TMO:US USD 11.12B 121M
Veracyte VCYT:US USD 58.35M 993K
Xencor XNCR:US USD 90.03M 14.99M
YTE INCY:US USD 1.01B 79.92M
Ziopharm Oncology ZIOP:US USD 32.87M 6.09M